- CureToday.com
- OncLive.com
- TargetedOnc.com
- Contact
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2021 MJH Life Sciences™ and Cancer Network. All rights reserved.
Gina Mauro | Authors
Articles
Lenalidomide/Rituximab Combo Improves PFS in Subgroup of Patients with NHL
December 09, 2019
Treatment with lenalidomide and rituximab improved progression-free survival, compared with placebo in patients ≥70 years old with indolent non-Hodgkin lymphoma.
Acalabrutinib Regimens Improve PFS in Treatment-Naïve Patients with CLL
December 08, 2019
Acalabrutinib alone and in combination with obinutuzumab significantly improved progression-free survival, compared with obinutuzumab plus chlorambucil in treatment-naïve patients with chronic lymphocytic leukemia
Frontline Ibrutinib/Venetoclax Provides High Rates of Undetectable MRD in CLL
December 08, 2019
First-line treatment with ibrutinib plus venetoclax provided high rates of undetectable minimal residual disease in peripheral blood and bone marrow of patients with chronic lymphocytic leukemia.